Novo Nordisk’s B shares are listed on Nasdaq Copenhagen in trading units of DKK 0.20 and its ADRs that equals B-shares of DKK 0.20 are listed on New York Stock Exchange (NYSE).
In order to secure liquidity for both the Novo Nordisk B shares and American Depositary Receipts (ADRs) and bring price levels in line with market practice for especially the ADRs, the Board of Directors has decided to split the trading units in a two-for-one ratio.
The trading unit of the Novo Nordisk B shares listed on NASDAQ Copenhagen was changed from DKK 0.20 to DKK 0.10 as of 13 September 2023. The ADRs listed on the New York Stock Exchange (NYSE) were similarly split as of 20 September 2023 to ensure that the ratio of B shares to ADRs will remain 1:1.
Novo Nordisk’s total share capital of DKK 451,000,000 is divided into an A share capital of nominally DKK 107,487,200 and a B share capital of nominally DKK 343,512,800.
After the split, the total number of A shares of nom. DKK 0.10 is 1,074,872,000 shares. Each A-share of nom. DKK 0,10 carries 100 votes. Consequently, the total number of votes relating to the A shares is 107,487,200,000 votes.
After the split, the total number of B shares of nom. DKK 0.10 is
3,435,128,000 shares. Each B-share of nom. DKK 0,10 carries 10 votes.
Consequently, the total number of votes relating to the B shares is
34,351,280,000 votes.
Computershare A/S, Lottenborgvej 26, 2800 Kgs. Lyngby, Denmark
- Website: www.computershare.dk
- Phone: +45 4546 0997 weekdays 9.00-15.00 (CEST)
- Email: info@computershare.dk
J.P. Morgan, Shareowner Services, P.O. Box 64504, St. Paul, MN
55164-0504
- Website: www.shareowneronline.com
- General: +1 800 990 1135
- From outside the U.S: +1 651 453 2128
- Global Invest Direct: +1 800 428 4237
Please find the company announcement regarding the stock split here
ABG Sundal Collier
Morten Larsen morten.larsen@abgsc.dk
Bank of America Merrill Lync
Sachin Jain s.jain@bofa.com
Barclays Capital
Emily Field emily.field@barclays.com
Berenberg
Kerry Holford kerry.holford@berenberg.com
Bernstein
Wimal Kapadia wimal.kapadia@bernstein.com
Carnegie Bank
Jesper Ilsøe jesper.ilsoe@carnegie.dk
Citigroup
Peter Verdult peter.verdult@citi.com
Cowen
Michael Nedelcovych michael.nedelcovych@cowen.com
Credit Suisse
Jo Walton jo.walton@credit-suisse.com
Danske Bank
Thomas Bowers thomas.bowers@danskebank.dk
Deutsche Bank
Emmanuel Papadakis emmanuel.papadakis@db.com
DNB Markets
Rune Majlund Dahl rune.dahl@dnb.no
Exane BNP Paribas
Richard Parkes richard.parkes@exanebnpparibas.com
Goldman Sachs
Keyur Parekh keyur.parekh@gs.com
Guggenheim
Seamus Fernadez seamus.fernandez@guggenheimpartners.com
Handelsbanken
Mattias Häggblom mattias.haggblom@handelsbanken.se
Intron Health
Naresh Chouhan naresh@intronhealthresearch.com
J.P. Morgan
Richard Vosser richard.vosser@jpmorgan.com
Jefferies & Company
Peter Welford pwelford@jefferies.com
Jyske Bank
Henrik Hallengreen Laustsen hla@jyskebank.dk
Kepler Cheuvreux
David Evans devans@keplercheuvreux.com
Morgan Stanley
Mark Purcell mark.purcell@morganstanley.com
Nordea Markets
Michael Novod michael.novod@nordea.com
Nykredit
Michael Drøscher Jørgensen midj@nykredit.dk
Oddo Securities
Martial Descoutures martial.descoutures@oddo-bhf.com
Redburn Partners
Simon Baker simon.baker@redburn.com
SEB
Martin Parkhøi martin.parkhoi@seb.dk
Société Générale
Florent Cespedes florent.cespedes@sgcib.com
Sydbank
Søren Løntoft Hansen s.loentoft@sydbank.dk
UBS
Michael Leuchten michael-a.leuchten@ubs.com
Investors
Share price
{{priceData.date}} {{priceData.time}}
